S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 0.439 DKK -1.57% Market Closed
Market Cap: 16.9m DKK

Stenocare A/S
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stenocare A/S
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Cash from Operating Activities
-kr7.1m
CAGR 3-Years
19%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Cash from Operating Activities
kr131.2B
CAGR 3-Years
25%
CAGR 5-Years
23%
CAGR 10-Years
15%
H Lundbeck A/S
CSE:HLUN A
Cash from Operating Activities
kr3.3B
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Cash from Operating Activities
kr1.3B
CAGR 3-Years
45%
CAGR 5-Years
50%
CAGR 10-Years
N/A

Stenocare A/S
Glance View

Market Cap
16.8m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.134 DKK
Overvaluation 69%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Cash from Operating Activities?
Cash from Operating Activities
-7.1m DKK

Based on the financial report for Dec 31, 2024, Stenocare A/S's Cash from Operating Activities amounts to -7.1m DKK.

What is Stenocare A/S's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-23%

Over the last year, the Cash from Operating Activities growth was 29%. The average annual Cash from Operating Activities growth rates for Stenocare A/S have been 19% over the past three years , -23% over the past five years .

Back to Top